<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialRecordOutput xmlns:ns2="local" id="251370"><TitleDisplay>Mesenteric traction syndrome and sevoflurane</TitleDisplay><TitleOfficial>Study of the effect of sevoflurane for mesenteric traction syndrome</TitleOfficial><OutcomesAvailable>No</OutcomesAvailable><EndpointsAchieved>Unknown</EndpointsAchieved><Identifiers><Identifier type="Secondary Organisational">UMIN000020619</Identifier></Identifiers><Indications><Indication id="19">Anesthesia</Indication></Indications><BiomarkerNames></BiomarkerNames><InterventionsPrimaryByRegimen regimenType="single"><Interventions><Intervention type="InterventionPrimary"><Name>sevoflurane</Name><Drug id="5356">sevoflurane</Drug></Intervention></Interventions></InterventionsPrimaryByRegimen><InterventionsControlByRegimens></InterventionsControlByRegimens><DrugsAsInterventionPrimary><DrugAsInterventionPrimary><Drug id="5356">sevoflurane</Drug><IndicationsPioneer></IndicationsPioneer><Companies><Company><Company id="1118740">Kiryu kosei general hospital</Company><RelationshipDirect>NONE</RelationshipDirect><RelationshipInDirect>NONE</RelationshipInDirect></Company></Companies></DrugAsInterventionPrimary></DrugsAsInterventionPrimary><CrossReferences><SourceEntity id="5356" type="Drug"><TargetEntity id="90235" type="siDrug">Sevoflurane</TargetEntity></SourceEntity><SourceEntity id="1118740" type="Company"><TargetEntity id="5049432630" type="organizationId">Kiryu Kosei General Hospital</TargetEntity></SourceEntity><SourceEntity id="19" type="ciIndication"><TargetEntity id="10002091" type="MEDDRA"></TargetEntity><TargetEntity id="D000758" type="MeSH"></TargetEntity><TargetEntity id="-564538434" type="omicsDisease"></TargetEntity><TargetEntity id="23" type="siCondition"></TargetEntity></SourceEntity></CrossReferences><Phase>Phase Not Applicable</Phase><RecruitmentStatus id="4">Completed</RecruitmentStatus><NumberOfSites>1</NumberOfSites><CompaniesSponsor><Company id="1118740">Kiryu kosei general hospital</Company></CompaniesSponsor><CompaniesCollaborator></CompaniesCollaborator><IsCommerciallySignificant>No</IsCommerciallySignificant><Class><Class id="1668">General anesthetic</Class><Class id="59620">Unspecified drug target</Class></Class><Technologies><Technology id="616">Inhalant formulation</Technology><Technology id="894">Liquid formulation</Technology><Technology id="762">Small molecule therapeutic</Technology></Technologies><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Retrospective</Term><Term>Observational</Term></TermsDesign><PatientCountEnrollment>40</PatientCountEnrollment><DateStart>2016-01-18T00:00:00Z</DateStart><DateChangeLast>2018-02-15T06:54:42Z</DateChangeLast><DateAdded>2016-05-21T00:00:00Z</DateAdded><Contacts><Contact type="Scientific contact"><Affiliation>Organization:  Kiryu kosei general hospital  ; Division name:  Anesthesiology</Affiliation><Email>harag.taka.gum@gmail.com</Email><Name>Takashi Haraguchi</Name><Phone>+81-277-44-7171</Phone></Contact><Contact type="Scientific contact"><Affiliation>Kiryu kosei general hospital ; Anesthesiology
</Affiliation><Email>harag.taka.gum@gmail.com</Email><Name>Takashi Haraguchi</Name><Phone>0277-44-7171</Phone></Contact><Contact type="Public contact"><Affiliation>Kiryu kosei general hospital ; Anesthesiology
</Affiliation><Email>harag.taka.gum@gmail.com</Email><Name>Takashi Haraguchi</Name><Phone>0277-44-7171</Phone></Contact></Contacts><CriteriaInclusion>&lt;Inclusion&gt;&lt;ul&gt;&lt;li&gt;Planning open surgery for gastric cancer&lt;/li&gt;&lt;/ul&gt;&lt;/Inclusion&gt;</CriteriaInclusion><CriteriaExclusion>&lt;Exclusion&gt;&lt;ul&gt;&lt;li&gt;Subjects taking NSAIDs&lt;/li&gt;&lt;li&gt;Bispectral index &gt; 60&lt;/li&gt;&lt;/ul&gt;&lt;/Exclusion&gt;</CriteriaExclusion><MeasuresOutcome><MeasuresPrimary><Measure><Description>Incidence of mesenteic traction syndrome during surgery</Description></Measure></MeasuresPrimary><MeasureSecondary></MeasureSecondary></MeasuresOutcome><ProtocolAndOutcomes><AimsAndScope>&lt;AimAndScope&gt;&lt;para&gt;The aim of this study was to evaluate whether the concentration of &lt;ulink linkType="Drug" linkID="5356"&gt;sevoflurane&lt;/ulink&gt; affected the incidence of mesenteic traction syndrome in abdominal surgery.&lt;/para&gt;&lt;/AimAndScope&gt;</AimsAndScope><ProtocolDescription>&lt;ProtocolDescription&gt;&lt;para&gt;In this study, the effect of concentration of sevoflurane affected the incidence of mesenteic traction syndrome in abdominal surgery would be observed.&lt;/para&gt;&lt;/ProtocolDescription&gt;</ProtocolDescription></ProtocolAndOutcomes><AdverseEventsByInterventions></AdverseEventsByInterventions><DoseRouteByInterventions></DoseRouteByInterventions><SitesByCountries><SitesByCountry country="Japan"><Sites><Site><Name>Kiryu kosei general hospital</Name><Address1>Kiryu</Address1><Contacts></Contacts></Site></Sites></SitesByCountry></SitesByCountries><PatientSegmentTerms></PatientSegmentTerms><TrialRegistries><Registry><Name id="1003">University Hospital Medical Information Network (UMIN)</Name><Identifiers><Identifier type="Secondary Organisational">UMIN000020619</Identifier></Identifiers></Registry></TrialRegistries><OutcomeMeasureTerms></OutcomeMeasureTerms><FundersType><Type>Company</Type></FundersType><ChangeHistory><Change type="added"><Date>2016-05-21T00:00:00Z</Date><Reason id="301">Clinical trial added</Reason></Change><Change type="updated"><Date>2018-02-15T00:00:00Z</Date><Reason id="302">Recruitment Status Changed</Reason></Change></ChangeHistory></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialRecordOutput>